Phenotyping Study of Cyclophosphamide 4-Hydroxylation in Malay Cancer Patients
Yesi Ihdina Fityatal Hasanah,1 Yahdiana Harahap,1,2 Denni Joko Purwanto3 1Bioavailability and Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia; 2Indonesia Defense University, Bogor 16810, West Java, Indonesia; 3Functional Medical Staff of Surgical Oncology, Dha...
I tiakina i:
Ngā kaituhi matua: | Fityatal Hasanah YI (Author), Harahap Y (Author), Purwanto DJ (Author) |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Dove Medical Press,
2021-01-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
mā: Sandi L. Navarro, me ētahi atu.
I whakaputaina: (2022) -
Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients
mā: Jeannine S. McCune, me ētahi atu.
I whakaputaina: (2022) -
Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
mā: Harahap Y, me ētahi atu.
I whakaputaina: (2020) -
Development and validation of a UPLC-MS/MS method with volumetric absorptive microsampling to quantitate cyclophosphamide and 4-hydroxycyclophosphamide
mā: Yahdiana Harahap, me ētahi atu.
I whakaputaina: (2022) -
Histamine as a marker for hydroxyl radicals
mā: T.-L. Ching, me ētahi atu.
I whakaputaina: (1995)